Immunization, Vaccines and Biologicals

SAGE working group on conjugate pneumococcal vaccine (March 2006 to March 2007)

Terms of Reference

  • To summarize existing evidence on the burden of pneumococcal disease in developing countries and the safety, immunogenicity, efficacy, and cost-effectiveness of pneumococcal conjugate vaccination in developing countries.
  • To provide SAGE with summaries and analyses needed to support its discussion and recommendation process.
  • To provide SAGE with a draft position statement for their review and approval, based on the data and the discussions and inputs of the SAGE membership.

Composition

SAGE Members

  • Art Reingold
  • Jose Ignacio Santos

Experts

  • Tatu Kamau, Kenya Expanded Programme for Immunization (KEPI)
  • Orin Levine, Johns Hopkins University, USA
  • Kate O'Brien, Johns Hopkins University, USA
  • Stephanie Schrag, Centers for Disease Control and Prevention, USA

WHO Secretariat

  • Thomas Cherian

Last reviewed: 24 September 2009

Share